tryptophanol has been researched along with 2-piperidone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amat, M; Bosch, J; Escolano, C; Gómez-Esqué, A; Molins, E; Santos, MM | 1 |
| Amat, M; Esplugas, R; Pereira, NA; Pérez, M; Santos, MM; Sureda, FX | 1 |
| Bessa, C; Bisio, A; Fernandes, J; Gomes, C; Gomes, S; Gonçalves, J; Inga, A; Monteiro, Â; Pereira, C; Pereira, NA; Queiroz, G; Raimundo, L; Reis, F; Santos, MM; Saraiva, L; Soares, J | 1 |
3 other study(ies) available for tryptophanol and 2-piperidone
| Article | Year |
|---|---|
Enantioselective formal synthesis of (+)-dihydrocorynantheine and (-)-dihydrocorynantheol.
Topics: Alkaloids; Cyclization; Indoles; Piperidones; Quinolizidines; Stereoisomerism; Tryptophan | 2009 |
Tryptophanol-derived oxazolopiperidone lactams: identification of a hit compound as NMDA receptor antagonist.
Topics: Animals; Cerebellum; Dose-Response Relationship, Drug; Indoles; Lactams; Molecular Structure; Neurons; Piperidones; Rats; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship; Tryptophan | 2014 |
Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Movement; Cell Proliferation; Colonic Neoplasms; High-Throughput Screening Assays; Humans; Immunoenzyme Techniques; Isoindoles; Mice; Mice, Inbred BALB C; Mice, Nude; Mutation; Oxazoles; Piperidones; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Small Molecule Libraries; Tryptophan; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2016 |